Back to Search
Start Over
New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia[R] (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
- Source :
- Business Wire. November 4, 2023
- Publication Year :
- 2023
-
Abstract
- * Interim results from FINE-REAL, a prospective, observational study evaluating clinical characteristics and treatment patterns in patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) treated with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.771496732